Ashley Ross and David Morris discuss the use of the Decipher Genomic Classifier in metastatic hormone-sensitive prostate cancer (mHSPC). They explore how Decipher can help stratify patients and guide treatment decisions, particularly in choosing between monotherapy, doublet, or triplet therapies. The discussion covers the STAMPEDE trial data, showing Decipher’s ability to predict treatment…
6,596 Followers, 639 Following, 2,517 Posts – See Instagram photos and videos from MedPage Today | Medical News (@medpage)
Blue light glasses claim to prevent eye damage from smartphones and computers. Do these glasses work? Here’s what an ophthalmologist says.
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over…
This special issue is in partnership with the ISSCR Athens International Symposium “Neural Stem Cells: Capturing Complexity and Plasticity from the Cell to the Organism,”…
Scientists say they’ve worked out how the plant can fire its seeds up to almost 40 feet.
CSSVs are often presumed to cause LoF and are assigned very strong evidence of pathogenicity. We found that approximately one in four CSSVs may not…
Phillip Koo and Neal Shore discuss the COBRA trial, which investigates the use of 64Cu-SAR-bisPSMA PET imaging in prostate cancer patients with biochemical recurrence (BCR).…
We are thrilled to share our new season of the Johns Hopkins Center for Health Equity (CHE) Jam Sessions! CHE invites speakers from a variety of research…
Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.
Highlights monthly webcast presentations for CE credit by FDA scientists from across agency on their cutting-edge scientific research
